Abstract:Pluripotency is established through genome-wide reprogramming during mammalian pre-implantation development, resulting in the formation of the naive epiblast. Reprogramming involves both the resetting of epigenetic marks and the activation of pluripotent-cell-specific genes such as Nanog and Oct4 (also known as Pou5f1). The tight regulation of these genes is crucial for reprogramming, but the mechanisms that regulate their expression in vivo have not been uncovered. Here we show that Nanog--but not Oct4--is monoallelically expressed in early pre-implantation embryos. Nanog then undergoes a progressive switch to biallelic expression during the transition towards ground-state pluripotency in the naive epiblast of the late blastocyst. Embryonic stem (ES) cells grown in leukaemia inhibitory factor (LIF) and serum express Nanog mainly monoallelically and show asynchronous replication of the Nanog locus, a feature of monoallelically expressed genes, but ES cells activate both alleles when cultured under 2i conditions, which mimic the pluripotent ground state in vitro. Live-cell imaging with reporter ES cells confirmed the allelic expression of Nanog and revealed allelic switching. The allelic expression of Nanog is regulated through the fibroblast growth factor-extracellular signal-regulated kinase signalling pathway, and it is accompanied by chromatin changes at the proximal promoter but occurs independently of DNA methylation. Nanog-heterozygous blastocysts have fewer inner-cell-mass derivatives and delayed primitive endoderm formation, indicating a role for the biallelic expression of Nanog in the timely maturation of the inner cell mass into a fully reprogrammed pluripotent epiblast. We suggest that the tight regulation of Nanog dose at the chromosome level is necessary for the acquisition of ground-state pluripotency during development. Our data highlight an unexpected role for allelic expression in controlling the dose of pluripotency factors in vivo, adding an extra level to the regulation of reprogramming.

Nanog fluctuations in ES cells highlight the problem of measurement in cell biology

Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells

Network plasticity of pluripotency transcription factors in embryonic stem cells

Nanog Dynamics in Mouse Embryonic Stem Cells: Results from Systems Biology Approaches

Deconstructing Transcriptional Heterogeneity in Pluripotent Stem Cells

A Heterogeneous Expression Pattern for Nanog in Embryonic Stem Cells

Analysis of Cell Lineage Trees by Exact Bayesian Inference Identifies Negative Autoregulation of Nanog in Mouse Embryonic Stem Cells.

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

Contribution of stochastic partitioning at human embryonic stem cell division to NANOG heterogeneity

Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells

The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells

Nanog and transcriptional networks in embryonic stem cell pluripotency

Nanog Induced Intermediate State in Regulating Stem Cell Differentiation and Reprogramming.

Nanog safeguards pluripotency and mediates germline development

Inductive and Selective Effects of GSK3 and MEK Inhibition on Nanog Heterogeneity in Embryonic Stem Cells.

Anti-phase clustering of regulatory factors shapes gene bursting

Pluripotential competence of cells associated with Nanog activity

Nanog Reporter System in Mouse Embryonic Stem Cells Based on Highly Efficient BAC Homologous Recombination

Control of ground-state pluripotency by allelic regulation of Nanog

Nanog promotes transfer of pluripotency after cell fusion

Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells